• Home
  • About Us
    • The People
    • Partnerships
    • In Memory
    • Careers
  • Research
    • Focus Areas
    • Projects
      • TeamLab
      • Ovarian MRD
      • KRAS in Pancreatic Cancer
      • Revolutionizing GBM Therapy
      • Intercepting Ovarian
  • Industry Partner Alliance
  • Media
Back to the top

Break Through Cancer

Collaborating for Cures

logo-lightlogo-dark
  • Home
  • About Us
    • The People
    • BTC Scientists
    • Partnerships
    • In Memory
    • Careers
  • Research
    • Focus Areas
    • Projects
      • BTC Funded Projects
      • Data Science Hub
      • Acute Myelogenous Leukemia
      • Glioblastoma
      • Ovarian Cancer
      • Pancreatic Cancer
  • Partner Alliance
  • Media
logo-lightlogo-dark

Detecting and Treating Minimal Residual Disease using liquid biopsy, May 26, 2021

June 21, 2021June 21, 2021 By Meredith Sandiford In webinar
0 likes4 views
Previous Cancer Vaccines: Imagining Cancer Vaccines in the COVID-19 era – June 2, 2021
Main Page

Break Through Cancer
101 Rogers Street
Suite 3A
Cambridge, MA 02142
Info@breakthroughcancer.org
1-800-757-9881

  • Careers
  • Opt-in for updates
  • Terms of Use
  • Privacy Policy
© Powered by WolfThemes